Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response

Yang Yang, Leilei Fan · 2026

Read Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response by Yang Yang, Leilei Fan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13554021.txt.

Description

Yang Yang and Leilei Fan scan a fat-carrying protein, APOC1, across thirty-three cancers in a 2026 study. The protein had been tied to several cancers, yet its wider role stayed unclear. The team combined gene, protein, and drug data from large public banks. They also used tissue maps and single-cell data to find which cells make the protein.

High levels appeared in most cancers and meant worse outcomes in kidney, brain, and stomach tumours even after other factors were weighed. The source proved to be macrophages, immune cells that settle inside tumours. High levels came with both immune attack signals and immune brakes, plus more cells that suppress attack. Tumours rich in the protein answered some drugs poorly yet may suit others, a lead for paired immune therapy.

Catalog record

CREATORYang Yang, Leilei Fan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60551
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13554021

Browse the full library · About the Tower of Babel